+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Primaquine Phosphate Tablets Market - Global Forecast 2026-2032- Product Image
Primaquine Phosphate Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Primaquine Phosphate Tablets Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122234
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Primaquine Phosphate Tablets Market is projected to reach USD 177.22 Million in 2026. It is expected to continue growing at a CAGR of 5.84%, reaching USD 250.56 Million by 2032.

Primaquine Phosphate Tablets: Executive Summary

Primaquine phosphate tablets are an established antimalarial therapy used primarily in radical cure and relapse prevention for Plasmodium vivax and, in selected protocols, as a transmission-reduction medicine for Plasmodium falciparum. Their use is shaped by malaria epidemiology, national treatment guidelines, medicine-quality requirements, diagnostic capacity, and the need to assess glucose-6-phosphate dehydrogenase (G6PD) status before treatment. Because hemolysis risk varies with G6PD deficiency, safe deployment depends on clinically appropriate patient selection, dosing, counseling, and follow-up.

Treatment Policy, Safety Controls, and Access Are Reshaping Use

The landscape is shifting from medicine availability alone toward integrated malaria case management. Health systems are placing greater emphasis on species confirmation, relapse prevention, G6PD testing, pharmacovigilance, procurement quality, and adherence support. Resistance surveillance and changing malaria-control priorities also influence where primaquine is recommended. Access remains uneven because tablet registration, supply continuity, diagnostic infrastructure, and trained healthcare personnel differ across endemic settings. These factors make implementation quality as important as the medicine itself.

Artificial Intelligence Strengthens Targeting, Safety, and Supply Planning

Artificial intelligence can support primaquine programs by improving malaria-risk mapping, identifying patients who may require follow-up, forecasting procurement needs, and detecting unusual adverse-event patterns in pharmacovigilance data. Machine-learning tools may also help interpret surveillance signals and prioritize outreach in areas with recurrent P. vivax transmission. However, AI does not replace G6PD testing, clinical judgment, validated diagnostics, or regulatory oversight. Its value depends on representative data, transparent validation, privacy safeguards, and workflows that remain usable in resource-constrained facilities.

Regional Insights: Differing Epidemiology and Health-System Readiness

North America primarily engages with primaquine through travel medicine, imported malaria management, specialist care, and public-health preparedness. Latin America requires approaches aligned with persistent P. vivax transmission, remote populations, and variability in diagnostic access. Europe combines imported-case management with research, regulatory oversight, and support for malaria elimination initiatives. The Middle East faces a mix of imported infections and localized public-health requirements, while Africa’s role is influenced by substantial malaria-control activity, species distribution, G6PD prevalence, and competing treatment priorities. Asia-Pacific remains especially important for P. vivax case management, cross-border transmission, rural access, and differentiated national protocols.

Group Insights: Coordinating Standards Across Diverse Health Systems

ASEAN countries share cross-border malaria risks and benefit from interoperable surveillance, consistent case-management guidance, and coordinated procurement and referral pathways. BRICS members span major malaria burdens, manufacturing capabilities, and varied regulatory environments, making harmonized quality assurance and evidence exchange valuable. The European Union emphasizes coordinated regulation, antimicrobial and antimalarial stewardship, and support for imported-case management. G7 members contribute through research, diagnostics, financing, and public-health partnerships. GCC countries focus largely on imported-case readiness, migrant and travel health, and laboratory capacity. NATO members may also require resilient medical supply chains and deployment-ready malaria protocols for personnel operating in endemic areas.

Country Insights: National Protocols Determine Practical Adoption

Australia and Japan emphasize travel-related prevention, imported-case diagnosis, and specialist prescribing. Brazil, India, China, Indonesia-linked ASEAN settings, and parts of the wider Asia-Pacific region must address P. vivax, rural access, and G6PD-informed treatment. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain primarily manage imported disease while supporting surveillance, clinical guidance, and international malaria initiatives. Mexico combines endemic-area control with imported-case preparedness. Russia’s needs vary by region and are influenced by travel-associated cases and public-health surveillance. South Korea focuses on prevention and management of locally relevant and imported malaria risks. Across all countries, reliable diagnostics, product quality, clinician education, and patient adherence remain central.

Action Priorities for Leaders: Build Safe, Resilient Primaquine Programs

Industry and health-system leaders should align product strategy with national malaria guidelines and invest in dependable quality systems, appropriate tablet presentations, and continuity of supply. Partnerships that expand accessible G6PD testing, provider training, adherence counseling, and adverse-event reporting can reduce avoidable treatment risk. Leaders should also strengthen demand planning using epidemiological and procurement data, support interoperability between laboratories and surveillance platforms, and evaluate AI tools through controlled implementation rather than unvalidated deployment. Equity should remain a practical objective: services must reach rural, mobile, and cross-border populations without weakening clinical safeguards.

Research Methodology: Evidence-Led Interpretation of the Market Reference

This executive summary uses the supplied market reference identifying primaquine phosphate tablets as the subject and applies a structured review of established clinical, public-health, regulatory, and health-system considerations. The analysis distinguishes documented therapeutic use from broader implementation implications and avoids unsupported numerical claims. Regional, group, and country observations are synthesized from known malaria epidemiology, treatment-policy principles, diagnostic requirements, and health-system characteristics. No market estimates, forecasts, market shares, or company-specific claims are included.

Conclusion: Safe Access and Integrated Delivery Will Define Progress

Primaquine phosphate tablets remain relevant where radical cure or transmission-reduction strategies are clinically indicated, but their effectiveness depends on more than tablet availability. The strongest programs connect accurate diagnosis, G6PD-informed prescribing, quality-assured procurement, adherence support, pharmacovigilance, and surveillance. Regional and national differences require tailored implementation, while cross-border collaboration can improve continuity of care. Leaders that prioritize safety, resilient supply, data quality, and equitable access will be better positioned to support responsible malaria control.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Primaquine Phosphate Tablets Market, by Strength
7.1. Introduction
7.2. 15 mg
7.3. 26.3 mg
7.4. 7.5 mg
8. Primaquine Phosphate Tablets Market, by Treatment Regimen
8.1. Introduction
8.2. Combination Therapy
8.3. Monotherapy
9. Primaquine Phosphate Tablets Market, by Packaging Type
9.1. Introduction
9.2. Blister Pack
9.3. Bottle
10. Primaquine Phosphate Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Primaquine Phosphate Tablets Market, by Patient Age
11.1. Introduction
11.2. Adult
11.3. Pediatric
12. Primaquine Phosphate Tablets Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Primaquine Phosphate Tablets Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Primaquine Phosphate Tablets Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Actiza Pharmaceutical Pvt. Ltd.
16.2. AdvaCare Pharma
16.3. Aurobindo Pharma Limited
16.4. Cipla Limited
16.5. Devlife Corporation Private Limited
16.6. Healthy Life Pharma Pvt. Ltd.
16.7. Hetero Drugs Limited
16.8. Intas Pharmaceuticals Limited
16.9. Ipca Laboratories Limited
16.10. Johnlee Pharmaceuticals Pvt. Ltd.
16.11. Lexicare Pharma Pvt. Ltd.
16.12. Livealth BioPharma Pvt. Ltd.
16.13. Lupin Limited
16.14. Marshall Healthcare
16.15. Medico Remedies Limited
16.16. Natco Pharma Limited
16.17. Sandoz International GmbH
16.18. Sun Pharmaceutical Industries Limited
16.19. Taj Pharmaceuticals Limited
16.20. Teva Pharmaceutical Industries Ltd.
16.21. Viatris Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Primaquine Phosphate Tablets Market, Years Considered for the Study
FIGURE 2. Global Primaquine Phosphate Tablets Market, Research Design
FIGURE 3. Global Primaquine Phosphate Tablets Market, Research Framework
FIGURE 4. Global Primaquine Phosphate Tablets Market, Data Triangulation
FIGURE 5. Global Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Primaquine Phosphate Tablets Market Size, by Strength, 2025 vs 2032 (%)
FIGURE 7. Global Primaquine Phosphate Tablets Market Size, by Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2025 vs 2032 (%)
FIGURE 9. Global Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Primaquine Phosphate Tablets Market Size, by Packaging Type, 2025 vs 2032 (%)
FIGURE 11. Global Primaquine Phosphate Tablets Market Size, by Packaging Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Primaquine Phosphate Tablets Market Size, by Patient Age, 2025 vs 2032 (%)
FIGURE 15. Global Primaquine Phosphate Tablets Market Size, by Patient Age, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Primaquine Phosphate Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Primaquine Phosphate Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Primaquine Phosphate Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Primaquine Phosphate Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Primaquine Phosphate Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Primaquine Phosphate Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Primaquine Phosphate Tablets Market Segmentation & Coverage
TABLE 2. Global Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 4. Global 15 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global 15 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global 15 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 26.3 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 26.3 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 26.3 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 7.5 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 7.5 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 7.5 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 14. Global Combination Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Combination Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Combination Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Monotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Monotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Monotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 21. Global Blister Pack Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Blister Pack Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Blister Pack Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Bottle Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Bottle Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Bottle Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 28. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 38. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 51. North America Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. North America Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 53. North America Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 54. North America Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 55. North America Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 56. North America Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 57. Latin America Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 59. Latin America Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 60. Latin America Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 61. Latin America Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. Latin America Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 63. Europe Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Europe Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 65. Europe Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 66. Europe Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 67. Europe Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Europe Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 69. Middle East Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Middle East Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 71. Middle East Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 72. Middle East Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 73. Middle East Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Middle East Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 75. Africa Primaquine Phosphate Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 77. Africa Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 78. Africa Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 79. Africa Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Africa Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 81. Global Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. ASEAN Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 84. ASEAN Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 85. ASEAN Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 86. ASEAN Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. ASEAN Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 88. GCC Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. GCC Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 90. GCC Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 91. GCC Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 92. GCC Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. GCC Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 94. European Union Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. European Union Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 96. European Union Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 97. European Union Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 98. European Union Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. European Union Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 100. BRICS Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. BRICS Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 102. BRICS Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 103. BRICS Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 104. BRICS Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. BRICS Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 106. G7 Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. G7 Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 108. G7 Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 109. G7 Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 110. G7 Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. G7 Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 112. NATO Primaquine Phosphate Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. NATO Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 114. NATO Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 115. NATO Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 116. NATO Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. NATO Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 118. Global Primaquine Phosphate Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. United States Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 120. United States Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 121. United States Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 122. United States Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 123. United States Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. United States Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 125. Canada Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 126. Canada Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 127. Canada Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 128. Canada Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 129. Canada Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Canada Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 131. Mexico Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 132. Mexico Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 133. Mexico Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 134. Mexico Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 135. Mexico Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Mexico Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 137. Brazil Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 138. Brazil Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 139. Brazil Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 140. Brazil Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 141. Brazil Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Brazil Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 143. United Kingdom Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 144. United Kingdom Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 145. United Kingdom Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 146. United Kingdom Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 147. United Kingdom Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. United Kingdom Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 149. Germany Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 150. Germany Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 151. Germany Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 152. Germany Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 153. Germany Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. Germany Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 155. France Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 156. France Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 157. France Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 158. France Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 159. France Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. France Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 161. Russia Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 162. Russia Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 163. Russia Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 164. Russia Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 165. Russia Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Russia Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 167. Italy Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 168. Italy Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 169. Italy Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 170. Italy Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 171. Italy Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Italy Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 173. Spain Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 174. Spain Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 175. Spain Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 176. Spain Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 177. Spain Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Spain Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 179. China Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 180. China Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 181. China Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 182. China Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 183. China Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. China Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 185. India Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 186. India Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 187. India Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 188. India Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 189. India Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. India Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 191. Japan Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 192. Japan Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 193. Japan Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 194. Japan Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 195. Japan Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Japan Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 197. Australia Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 198. Australia Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 199. Australia Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 200. Australia Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 201. Australia Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Australia Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 203. South Korea Primaquine Phosphate Tablets Market Size, 2017-2032 (USD Million)
TABLE 204. South Korea Primaquine Phosphate Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 205. South Korea Primaquine Phosphate Tablets Market Size, by Treatment Regimen, 2017-2032 (USD Million)
TABLE 206. South Korea Primaquine Phosphate Tablets Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 207. South Korea Primaquine Phosphate Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. South Korea Primaquine Phosphate Tablets Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 209. Global Primaquine Phosphate Tablets Market Share, by Key Player, 2025
TABLE 210. Global Primaquine Phosphate Tablets Market, Key Experts

Companies Mentioned

  • Actiza Pharmaceutical Pvt. Ltd.
  • AdvaCare Pharma
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Devlife Corporation Private Limited
  • Healthy Life Pharma Pvt. Ltd.
  • Hetero Drugs Limited
  • Intas Pharmaceuticals Limited
  • Ipca Laboratories Limited
  • Johnlee Pharmaceuticals Pvt. Ltd.
  • Lexicare Pharma Pvt. Ltd.
  • Livealth BioPharma Pvt. Ltd.
  • Lupin Limited
  • Marshall Healthcare
  • Medico Remedies Limited
  • Natco Pharma Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Taj Pharmaceuticals Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Primaquine Phosphate (CAS 63-45-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Primaquine Phosphate (CAS 63-45-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Primaquine (CAS 90-34-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Primaquine (CAS 90-34-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast 2026-2032 - Product Image

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Linagliptin Tablets Market - Global Forecast 2026-2032 - Product Image

Linagliptin Tablets Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Enterprise Tablets - Global Strategic Business Report - Product Image

Enterprise Tablets - Global Strategic Business Report

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.